SSGJ-629

N/A

Report date: 2026/04/29 20:02:18
NME

Base Information

Drug NameSSGJ-629
Drug Alias NameSSGJ-629SSGJ629
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 23 Receptor inhibitors
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator Companies3sbio Inc
China Registration ClassN/A

Develop Information

Active Companies3sbio Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A